Vitamin D Deficiency is Common in HIV-Infected Southern Australian Adults

Abstract

Background

Vitamin D deficiency can have serious health consequences and may be particularly important for those living with HIV. It is unknown whether HIV infection is a risk factor for vitamin D deficiency. The aim of the study was to determine whether vitamin D deficiency is more common in HIV-infected than in HIV-uninfected individuals.

Methods

This was a cross-sectional study of HIV-infected and uninfected individuals. A total of 997 HIV-infected participants were from a sexual health clinic in Melbourne with 25(OH)D measurements taken between 2008 and 2012. 3,653 HIV-uninfected individuals were participants in a statewide Victorian survey with 25(OH)D measurements taken between 2009 and 2010. Logistic regression models evaluated the association of HIV status with vitamin D deficiency (25[OH]D<50 nmol/l).

Results

The frequency of vitamin D deficiency was significantly more common in HIV-infected (39% [95% CI 36%, 42%]) compared with HIV-uninfected individuals 23% (95% CI 15%, 31%). In multivariable analysis, males (adjusted odds ratio [aOR] 0.8; 95% CI 0.6, 0.9; P=0.001), Caucasian country of origin (aOR 0.4; 95% CI 0.3, 0.4; P<0.001), summer/autumn (aOR for autumn 0.2; 95% CI 0.1, 0.3; P<0.001), total cholesterol to high-density lipoprotein ratio >5 (aOR 1.4; 95% CI 1.2, 1.8; P<0.001) and HIV infection (aOR 1.7; 95% CI 1.4, 2.1; P<0.001) were associated with vitamin D deficiency.

Conclusions

Adults living in southern Australia with HIV were more likely to be vitamin D deficient than the general population.

References

Yin

Vitamin D, bone, and HIV infection.

Top Antivir Med 2012; 20: 168–172.

Khoo

A.L.

, Chai

, Koenen

, Joosten

, Netea

, van der Ven

Translating the role of vitamin D(3) in infectious diseases.

Crit Rev Microbiol 2012; 38: 122–135.

Fitch

, Grinspoon

Nutritional and metabolic correlates of cardiovascular and bone disease in HIV-infected patients.

Am J Clin Nutr 2011; 94: 1721S–1728S.

Bischoff-Ferrari

H.A.

Vitamin D and fracture prevention.

Endocrinol Metab Clin North Am 2010; 39: 347–353.

Heaney

R.P.

Vitamin D and calcium interactions: functional outcomes.

Am J Clin Nutr 2008; 88: 541S–544S.

The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia: Annual Surveillance Report 2013: The Kirby Institute, The University of New South Wales, Sydney NSW 2052; 2013. (Updated 21 October 2013. Accessed 23 June 2014.) Available from https://kirby.unsw.edu.au/surveillance/2013-annual-surveillance-report-hiv-viral-hepatitis-stis.

Australian Bureau of Statistics. Population by age and sex, Australian states and territories Canberra, Australia: Australian Bureau of Statistics; 2006. Available from http://www.abs.gov.au/websitedbs/censushome.nsf/home/Census?opendocument.

Jablonski

N.G.

, Chaplin

The evolution of human skin coloration.

J Hum Evol 2000; 39: 57–106.

Central Intelligence Agency. The World Factbook 2013–14 2013 (Accessed 5 March 2013.) Available from https://www.cia.gov/library/publications/the-world-factbook/index.html.

10.

Dao

C.N.

, Patel

, Overton

E.T.

Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population.

Clin Infect Dis 2011; 52: 396–405.

11.

Klassen

K.M.

, Fairley

C.K.

, Kimlin

M.G.

Ultraviolet index and location are important determinants of vitamin D status in people with human immunodeficiency virus.

Photochem Photobiol 2015; 91: 431–437.

12.

Childs

, Welz

, Samarawickrama

, Post

F.A.

Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients.

AIDS 2012; 26: 253–262.

13.

Ross

A.C.

, Manson

J.E.

, Abrams

S.A.

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know.

J Clin Endocrinol Metab 2011; 96: 53–58.

14.

Nowson

C.A.

, McGrath

J.J.

, Ebeling

P.R.

Vitamin D and health in adults in Australia and New Zealand: a position statement.

Med J Aust 2012; 196: 686–687.

15.

Holick

M.F.

, Binkley

N.C.

, Bischoff-Ferrari

H.A.

Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.

J Clin Endocrinol Metab 2011; 96: 1911–1930.

16.

Levey

A.S.

, Stevens

L.A.

, Schmid

C.H.

A new equation to estimate glomerular filtration rate.

Ann Intern Med 2009; 150: 604–612.

17.

Natarajan

, Glick

, Criqui

, Horowitz

, Lipsitz

S.R.

, Kinosian

Cholesterol measures to identify and treat individuals at risk for coronary heart disease.

Am J Prev Med 2003; 25: 50–57.

18.

Klassen

K.M.

, Fairley

C.K.

, Kimlin

M.G.

Ultraviolet index and location are important determinants of vitamin D status in people with human immunodeficiency virus (HIV).

Photochem Photobiol 2015; 91: 431–437.

19.

Stein

E.M.

, Yin

M.T.

, McMahon

D.J.

Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women.

Osteoporos Int 2011; 22: 477–487.

20.

Stephensen

C.B.

, Marquis

G.S.

, Kruzich

L.A.

, Douglas

S.D.

, Aldrovandi

G.M.

, Wilson

C.M.

Vitamin D status in adolescents and young adults with HIV infection.

Am J Clin Nutr 2006; 83: 1135–1141.

21.

Adeyemi

O.M.

, Agniel

, French

A.L.

Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States.

J Acquir Immune Defic Syndr 2011; 57: 197–204.

22.

García Aparicio

A.M.

, Muñoz Fernández

, González

Abnormalities in the bone mineral metabolism in HIV-infected patients.

Clin Rheumatol 2006; 25: 537–539.

23.

Teichmann

, Stephan

, Lange

Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.

J Infect 2003; 46: 221–227.

24.

Fox

, Peters

, Prakash

, Arribas

, Hill

, Moecklinghoff

Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET Trial.

AIDS Res Hum Retroviruses 2011; 27: 29–34.

25.

Cervero

, Agud

J.L.

, Garcia-Lacalle

Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapy.

AIDS Res Hum Retroviruses 2012; 28: 963–971.

26.

Allavena

, Delpierre

, Cuzin

High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs.

J Antimicrob Chemother 2012; 67: 2222–2230.

27.

Cozzolino

, Vidal

, Arcidiacono

, Tebas

, Yarasheski

, Dusso

HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D.

AIDS 2003; 17: 513–520.

28.

Viard

J.P.

, Souberbielle

J.C.

, Kirk

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study.

AIDS 2011; 25: 1305–1315.

29.

Ellfolk

, Norlin

, Gyllensten

, Wikvall

Regulation of human vitamin D(3) 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells.

Mol Pharmacol 2009; 75: 1392–1399.

30.

Hariparsad

, Nallani

S.C.

, Sane

R.S.

, Buckley

D.J.

, Buckley

A.R.

, Desai

P.B.

Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital.

J Clin Pharmacol 2004; 44: 1273–1281.

31.

Risley

J.M.

Cholesterol biosynthesis: lanosterol to cholesterol.

J Chem Educ 2002; 79: 377–384.

32.

Bogh

M.K.

, Schmedes

A.V.

, Philipsen

P.A.

, Thieden

, Wulf

H.C.

Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation.

J Invest Dermatol 2010; 130: 546–553.

33.

So-Armah

K.A.

, Chang

, Alcorn

HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function.

Curr HIV Res 2014; 12: 50–59.

34.

Blair

, Byham-Gray

, Lewis

, McCaffrey

Prevalence of vitamin D 25(OH)D deficiency and effects of supplementation with ergocalciferol (vitamin D(2)) in stage 5 chronic kidney disease patients.

J Ren Nutr 2008; 18: 375–382.

35.

Rosenvinge

M.M.

, Gedela

, Copas

A.J.

Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency.

J Acquir Immune Defic Syndr 2010; 54: 496–499.

36.

Erlandson

K.M.

, Allshouse

A.A.

, Jankowski

C.M.

, Mawhinney

, Kohrt

W.M.

, Campbell

T.B.

Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection.

J Acquir Immune Defic Syndr 2013; 63: 209–215.

37.

Daly

R.M.

Independent and combined effects of exercise and vitamin D on muscle morphology, function and falls in the elderly.

Nutrients 2010; 2: 1005–1017.